Look for:

Products

CHUGAI PHARMACEUTICAL CO LTD


ISIN:
JP3519400000
WKN:
4519

2024/04/18 08:00:00
Price
5,090.00 JPY
Difference 0.49% (25.00)

General attributes

ISINJP3519400000
Symbol4519
ExchangeTokyo Stock Exchange
CurrencyJPY
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)51,902 EUR
BenchmarkNIKKEI 225

Market data

Bid (Bid size)5,089.00 JPY (200)
Ask (Ask size)5,096.00 JPY (1,000)
Open5,038.00 JPY
High5,096.00 JPY
Low4,997.00 JPY
Close (prev. day)5,065.00 JPY
VWAP5,061.6183 JPY
Volume (pcs)2,472,600
Trading volume125,153,573.00
Number of trades6,074
Last size802,500

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: CHUGAI PHARMACEUTICAL CO LTDPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/04/18 08:00:00
Price
5,090.00 JPY
Difference 0.49% (25.00)

General attributes

ISINJP3519400000
Symbol4519
ExchangeTokyo Stock Exchange
CurrencyJPY
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)51,902 EUR
BenchmarkNIKKEI 225

Market data

Bid (Bid size)5,089.00 JPY (200)
Ask (Ask size)5,096.00 JPY (1,000)
Open5,038.00 JPY
High5,096.00 JPY
Low4,997.00 JPY
Close (prev. day)5,065.00 JPY
VWAP5,061.6183 JPY
Volume (pcs)2,472,600
Trading volume125,153,573.00
Number of trades6,074
Last size802,500

Performance and Risk

6m1Y3Y
Perf (%)+9.20%+51.89%+17.82%
Perf (abs.)+429.00+1,739.00+770.00
Beta0.840.850.84
Volatility29.9327.0127.49
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)5,125.60 JPY (2,395,340)
Ø price 30 days | Ø volume 30 days (pcs.)5,745.60 JPY (2,475,990)
Ø price 100 days | Ø volume 100 days (pcs.)5,581.23 JPY (2,332,894)
Ø price 250 days | Ø volume 250 days (pcs.)4,722.48 JPY (2,285,897)
YTD High | date6,697.00 JPY (2024/03/11)
YTD Low | date4,960.00 JPY (2024/04/16)
52 Weeks High | date6,697.00 JPY (2024/03/11)
52 Weeks Low | date3,241.00 JPY (2023/04/21)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/04/1822:2630.72 EUR0.001
Tokyo Stock Exchange2024/04/1808:005,090.00 JPY125.156,074
Stuttgart2024/04/1808:0230.50 EUR0.003
Munich2024/04/1808:0030.61 EUR0.002
Hanover2024/04/1808:0030.10 EUR0.003
Frankfurt2024/04/1815:2930.25 EUR0.005
FINRA other OTC Issues2024/04/1217:5633.27 USD0.002
Duesseldorf2024/04/1819:3030.26 EUR0.007
Berlin2024/04/1821:0530.69 EUR0.008

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=6496&ID_TYPE_IMAGE_LOGO=2

Contact Details

CHUGAI PHARMACEUTICAL CO. LTD.
- -
Nihonbashi Mitsui Tower, 15/F, 2-1-1 Nihonbashi-Muromachi - 103-8324 Tokyo
Telefon: +81-3-3281-6611
Fax: +81-3-3281-6607
E-mail: -

PDF Downloads

Company report: CHUGAI PHARMACEUTICAL CO LTDPDF Download

Company Profile

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Members of Management Board

Osamu OkudaChairman of Managing Board
Hisafumi YamadaMember of Executive Committee
Junichi EbiharaMember of Executive Committee
Satoko ShisaiMember of Executive Committee
Shinji HidakaMember of Executive Committee
Tetsuya YamaguchiMember of Executive Committee
Toshiaki ItagakiMember of Executive Committee
Yoshiyuki YanoMember of Executive Committee

Board of directors

Christoph FranzMember of Supervisory Board
James SabryMember of Supervisory Board
Iwaaki TaniguchiMember of Supervisory Board
Mariko MomoiMember of Supervisory Board
Masayuki OkuMember of Supervisory Board
Motoo UenoMember of Supervisory Board
William AndersonMember of Supervisory Board
Yoichiro IchimaruMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.